Martin R - Search Results

1

CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2.

Zipp F, Faber E, Sommer N, Müller C, Dichgans J, Krammer PH, Martin R, Weller M. Zipp F, et al. Among authors: martin r. J Neuroimmunol. 1998 Jan;81(1-2):168-72. doi: 10.1016/s0165-5728(97)00173-2. J Neuroimmunol. 1998. PMID: 9521618

2

[Influence of genetic factors on multiple sclerosis].

Sommer N, Zipp F, Rösener M, Dichgans J, Martin R. Sommer N, et al. Among authors: martin r. Nervenarzt. 1996 Jun;67(6):457-64. Nervenarzt. 1996. PMID: 8767200 Review. German.

3

Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.

Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M. Zipp F, et al. Among authors: martin r. J Immunol. 1997 Sep 1;159(5):2108-15. J Immunol. 1997. PMID: 9278296

4

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis.

Zipp F, Weller M, Calabresi PA, Frank JA, Bash CN, Dichgans J, McFarland HF, Martin R. Zipp F, et al. Among authors: martin r. Ann Neurol. 1998 Jan;43(1):116-20. doi: 10.1002/ana.410430120. Ann Neurol. 1998. PMID: 9450777

5

Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis.

Zipp F, Otzelberger K, Dichgans J, Martin R, Weller M. Zipp F, et al. Among authors: martin r. J Neuroimmunol. 1998 Jun 15;86(2):151-4. doi: 10.1016/s0165-5728(98)00032-0. J Neuroimmunol. 1998. PMID: 9663560

6

Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.

Zipp F, Windemuth C, Pankow H, Dichgans J, Wienker T, Martin R, Müller C. Zipp F, et al. Among authors: martin r. Hum Immunol. 2000 Oct;61(10):1021-30. doi: 10.1016/s0198-8859(00)00173-7. Hum Immunol. 2000. PMID: 11082515

7

2',3'-cyclic nucleotide 3'-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases.

Rösener M, Muraro PA, Riethmüller A, Kalbus M, Sappler G, Thompson RJ, Lichtenfels R, Sommer N, McFarland HF, Martin R. Rösener M, et al. Among authors: martin r. J Neuroimmunol. 1997 May;75(1-2):28-34. doi: 10.1016/s0165-5728(96)00230-5. J Neuroimmunol. 1997. PMID: 9143234

8

[Multiple sclerosis. New therapeutic strategies in the experimental stage].

Zipp F, Sommer N, Rösener M, Dichgans J, Martin R. Zipp F, et al. Among authors: martin r. Nervenarzt. 1997 Feb;68(2):94-101. doi: 10.1007/s001150050103. Nervenarzt. 1997. PMID: 9173318 Review. German.

9

Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function.

Zipp F, Windemuth C, Dichgans J, Wienker T, Martin R, Müller C. Zipp F, et al. Among authors: martin r. Immunol Lett. 2001 Aug 1;78(1):21-7. doi: 10.1016/s0165-2478(01)00227-9. Immunol Lett. 2001. PMID: 11470147

10

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease.

Sommer N, Martin R, McFarland HF, Quigley L, Cannella B, Raine CS, Scott DE, Löschmann PA, Racke MK. Sommer N, et al. Among authors: martin r. J Neuroimmunol. 1997 Oct;79(1):54-61. doi: 10.1016/s0165-5728(97)00111-2. J Neuroimmunol. 1997. PMID: 9357447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,346 results

Search Page

Filters